Saluda Medical Highlights Multiple Presentations Featuring Evoke ECAP-Controlled, Closed-Loop SCS System at NANS Annual Meeting

Includes 8 Oral Presentations and Award of Best Clinical Abstract

ARTARMON, Australia, Jan. 21, 2020 /PRNewswire/ -- Saluda Medical Pty Limited ("Saluda Medical") today announced that data from multiple studies evaluating the company's Evoke ECAP-Controlled, Closed-Loop Spinal Cord Stimulation (SCS) System for the treatment of chronic pain will be featured in multiple presentations – including eight oral presentations and award of Best Clinical Abstract – during the upcoming North American Neuromodulation Society (NANS) 23^rd Annual Meeting, being held January 23-26, 2020 in Las Vegas, Nevada.

Evoke is the first closed-loop SCS system that is designed to measure the spinal cord's response to stimulation (via ECAPs, or evoked compound action potentials) and adjust on every pulse to optimize activation within the patient's therapeutic window.

Oral presentations by leading pain specialists will feature results out to 12 months from the Evoke U.S. Pivotal Study, which were recently published in The Lancet Neurology. These results were awarded The Best Clinical Abstract by NANS and will be presented on the podium by Timothy Deer, MD, President and CEO of The Spine & Nerve Centers in Charleston, WV and Past President of the International Neuromodulation Society. In addition, final results out to 24 months from the Avalon multicenter chronic study will be presented. Other presentations by Evoke study investigators will include discussions of various sub-analyses from the Evoke data.

John Parker, CEO of Saluda Medical, commented, "We look forward to hearing from investigators who will be sharing long-term results out to 12 months from the U.S. Evoke Pivotal Study and out to 24 months from the Avalon study. We are honored to have the studies of our device given such attention as NANS represents a meaningful opportunity for leading clinical neurologists and pain specialists to share scientific and medical developments in the treatment of pain."

Details of the presentations include: 

Oral Presentations
• Avalon Study: Long-Term Impact of ECAP-Controlled Closed-Loop SCS on Pain, Patient Wellbeing and Clinical Practice
	º Session: